DEADLINE ALERT for RIDE, BHC, SYNH, and T: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
04 août 2023 11h06 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Syneos Health Stockholders Approve Agreement with Private Investment Consortium
02 août 2023 08h47 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today...
Moore Kuehn Encourages SYNH, SPPI, ARNC and EMBK Investors to Contact Law Firm
03 juil. 2023 11h37 HE
|
Moore Kuehn
NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
Syneos Health Reports First Quarter 2023 Results
10 mai 2023 07h07 HE
|
Syneos Health, Inc.
Revenue for the first quarter of $1,356.8 million increased 1.5% on a reported basis and increased 2.4% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health to be Acquired by a Private Investment Consortium for Approximately $7.1 Billion
10 mai 2023 06h47 HE
|
Syneos Health, Inc.
Shareholders to Receive $43.00 Per Share in Cash Represents 24% Premium to Unaffected Stock Price MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos...
Syneos Health Appoints Michael Bonello as Chief Financial Officer
02 mai 2023 06h19 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael...
Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023
08 févr. 2023 21h41 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year...
Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab
11 janv. 2023 07h10 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health to Participate in Fireside Chat at the 2022 Evercore ISI HealthCONx Conference
17 nov. 2022 16h44 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Syneos Health Adds HUB Patient Suite to Deployment Solutions Business
27 oct. 2022 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a dedicated...